(Q43853358)

English

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry

scientific article published on 18 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

focused ultrasound

0 references

Xavier Rebillard

8

object named as

Xavier Rebillard

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

object named as

Roman Ganzer

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

11

object named as

Andreas Blana

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Cary N Robertson

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

John F Ward

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Stephen C W Brown

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Giario N Conti

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Francois J Murat

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Gilles Pasticier

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Stefan Thuroff

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Wolf F Wieland

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

18 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

108

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

8 Pt 2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

E196-201

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

To what extent does the prostate-specific antigen nadir predict subsequent treatment failure after transrectal high-intensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Eight years' experience with high-intensity focused ultrasonography for treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Control of prostate cancer by transrectal HIFU in 227 patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10091.X

21 January 2018

Identifiers

10.1111/J.1464-410X.2011.10091.X

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43853358&oldid=2103902239"